NDC 80425-0050-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0050
- Requested NDC
- 80425-0050-01
- Package NDCs from labels
- 80425-0050-2, 80425-0050-1, 80425-0050-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0050-1 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 6 | |
| 80425-0050-2 | Naproxen | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0050 | NAPROXEN TABLET [ADVANCED RX OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20250101_af9aa7a0-e287-5935-e053-2995a90a1d11.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0050-1 | EA - Each | 80425-0050 | 42db3f9d-30eb-4317-9ff5-cacb1fe8161e | 1 | 2023-06-06 |
| 80425-0050-2 | EA - Each | 80425-0050 | d33960a5-6523-4a80-b4e6-0fa5094a6aad | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NAPROXEN | NAPROXEN | Northwind Health Company, LLC | f32d755e-4984-ee40-e053-2995a90a4ebe | 2026-01-01 | Warnings | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | fb07a76b-98ce-85dd-e053-6294a90aa6a8 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | ab6ec2c9-5df9-346c-e053-2a95a90ac81d | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | db478961-d984-7c8e-e053-2995a90a8a12 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Northwind Health Company, LLC | c986ba9a-6f48-8347-e053-2a95a90aa1c1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | QPharma, Inc. | 307aa67f-53b9-4c60-a328-091bbf6338d4 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | Glenmark Pharmaceuticals Inc., USA | 6c5bb008-e66f-4ef0-bf84-aca7eb5983e9 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | ANDA078250 68462-190 849431 849398 198014 198013 198012 16372549-a419-4920-a200-5128017570ed 6c5bb008-e66f-4ef0-bf84-aca7eb5983e9 9TN87S3A3C 57Y76R9ATQ |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Ajanta Pharma USA Inc. | 7ca657dc-4376-4693-8568-99351fac8186 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | Granules USA, Inc. | 8cb8030c-b281-315c-e053-2a95a90a36f0 | 2025-12-22 | Warnings | 9TN87S3A3C |
| Naproxen Sodium Diphenhydramine HCL | NAPROXEN SODIUM DIPHENHYDRAMINE HCL | Walmart | fe810c0e-ab42-5a8a-e053-6394a90affe4 | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Safeway, Inc | f2a273f8-d623-dc2f-e053-2995a90a0c02 | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | Safeway, Inc | f2a297c2-3898-5e47-e053-2995a90ab3cc | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | TARGET CORPORATION | fdb87abd-3176-dd62-e053-6394a90a6fcc | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium and Diphenhydramine HCL | NAPROXEN SODIUM AND DIPHENHYDRAMINE HCL | TARGET CORPORATION | fe82699d-fdc2-038e-e053-6294a90a606c | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium Diphenhydramine HCl | NAPROXEN SODIUM DIPHENHYDRAMINE HCL | CVS PHARMACY, INC | bdac694e-ab2a-376d-e053-2a95a90a9467 | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | CVS | 1042b202-e8ee-1839-e063-6294a90ac90b | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | CVS | 10429d07-de96-5542-e063-6294a90a7371 | 2025-12-19 | Warnings | 9TN87S3A3C |
| Naproxen Sodium Diphenhydramine Hydrochloride | NAPROXEN SODIUM DIPHENHYDRAMINE HYDROCHLORIDE | SAFEWAY | ed0f3275-f156-13a3-e053-2a95a90a2ce8 | 2025-12-18 | Warnings | 9TN87S3A3C |
| signature care naproxen sodium | NAPROXEN SODIUM | Safeway | 85f78e63-98aa-4cf3-887d-0ac535184f97 | 2025-12-16 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | MEIJER DISTRIBUTION INC | 89f82399-9f71-49dd-8710-b60f346c576c | 2025-12-12 | Warnings | 9TN87S3A3C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.